$3.77▼-0.14 (-3.58%)
AQST stories
written from corroborating sources- Aquestive Therapeutics Reports Q2 2026 Financial Results With $5.2 Million Revenue
Aquestive Therapeutics reported a revenue of $5.2 million for the second quarter of 2026, reflecting a significant increase compared to the previous year. The company also provided a business update, highlighting ongoing developments in its product pipeline and strategic initiatives.
Earnings·2 articles / 2 outlets·96d ago·◆ Primary source
More AQST headlines
1 articleLatest story Refreshed every 5 minutes; wire stories every 15 minutesAbout this data
Explore More
AQST Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance